U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.7865C>T (p.Ala2622Val) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001026887.12

Allele description [Variation Report for NM_000051.4(ATM):c.7865C>T (p.Ala2622Val)]

NM_000051.4(ATM):c.7865C>T (p.Ala2622Val)

Genes:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
C11orf65:chromosome 11 open reading frame 65 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.7865C>T (p.Ala2622Val)
HGVS:
  • NC_000011.10:g.108332838C>T
  • NG_009830.1:g.115007C>T
  • NG_054724.1:g.141995G>A
  • NM_000051.4:c.7865C>TMANE SELECT
  • NM_001330368.2:c.641-23767G>A
  • NM_001351110.2:c.*38+2382G>A
  • NM_001351834.2:c.7865C>T
  • NP_000042.3:p.Ala2622Val
  • NP_000042.3:p.Ala2622Val
  • NP_001338763.1:p.Ala2622Val
  • LRG_135t1:c.7865C>T
  • LRG_135:g.115007C>T
  • LRG_135p1:p.Ala2622Val
  • NC_000011.9:g.108203565C>T
  • NM_000051.3:c.7865C>T
Protein change:
A2622V
Links:
dbSNP: rs766351395
NCBI 1000 Genomes Browser:
rs766351395
Molecular consequence:
  • NM_001330368.2:c.641-23767G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001351110.2:c.*38+2382G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000051.4:c.7865C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.7865C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001189357Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Jan 11, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengüt S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P.

Am J Hum Genet. 1999 Jun;64(6):1617-31.

PubMed [citation]
PMID:
10330348
PMCID:
PMC1377904

Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.

Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, Dörk T, Burge C, Gatti RA.

Hum Mutat. 2004 Jan;23(1):67-76.

PubMed [citation]
PMID:
14695534
See all PubMed Citations (6)

Details of each submission

From Ambry Genetics, SCV001189357.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

The c.7865C>T pathogenic mutation (also known as p.A2622V), located in coding exon 52 of the ATM gene, results from a C to T substitution at nucleotide position 7865. The alanine at codon 2622 is replaced by valine, an amino acid with similar properties. This alteration has been detected in a homozygous state in multiple individuals with Ataxia Telangiectasia (Teraoka SN et al. Am. J. Hum. Genet., 1999 Jun;64:1617-31; Eng L et al. Hum. Mutat., 2004 Jan;23:67-76; Heinrich T et al. Eur. J. Pediatr., 2006 Apr;165:250-7; Aghamohammadi A et al. J Investig Allergol Clin Immunol, 2010;20:442-5). In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. RNA analyses have shown that this alteration creates a new splice donor site, resulting in a deletion of 64 nucleotides from exon 52 and an out of frame transcript (Teraoka SN et al. Am. J. Hum. Genet., 1999 Jun;64:1617-31, Eng L et al. Hum. Mutat., 2004 Jan;23:67-76, Du L et al. Proc. Natl. Acad. Sci. U.S.A., 2007 Apr;104:6007-12, Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 8, 2024